PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jarospringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
J Assoc Res Otolaryngol. 2003 June; 4(2): 139–147.
Published online 2002 November 5. doi:  10.1007/s10162-002-3025-7
PMCID: PMC3202716

Proinflammatory Cytokine Expression in the Endolymphatic Sac During Inner Ear Inflammation

Abstract

The inner ear is capable of rapidly mounting an immune response that can ultimately lead to cochlear degeneration and permanent hearing loss. The role of the endolymphatic sac in this immune process is not clear. In order to investigate the cytokine expression of cells within the endolymphatic sac, a secondary inner ear immune response to keyhole limpet hemocyanin (KLH) was created in mice. The animals were sacrificed 3–48 h and 7 days following initiation of the immune response. The cochleas and endolymphatic sacs were assayed by immunocytochemistry for IL-1β, TNFα, and IL-6. Three hours after KLH challenge of the scala tympani, the perisaccular tissue of the endolymphatic sac contained more inflammatory cells than the scala tympani or endolymphatic sac lumen. Only a few of these cells, however, expressed the proinflammatory cytokines IL-1β and TNFα between 3 and 12 h after KLH injection. On the other hand, TNFα, which plays an important role in the cochlear secondary immune response, was expressed in cells in the endolymphatic sac lumen. The maximum percentage of cells expressing TNFα was seen later than in the scala tympani. Animals treated with systemic injection of the TNF blocker, etanercept, showed a reduction in the number of cells in the endolymphatic sac lumen. It is concluded that the cells in the endolymphatic sac lumen contribute to the amplification of the adaptive immune response by expressing TNFα, while the infiltration of cells into the perisaccular connective tissue is part of the nonspecific, innate, cochlear immune response.

Full Text

The Full Text of this article is available as a PDF (227K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Adams JC. Clinical implications of inflammatory cytokines in the cochlea. Otol. Neurotol. 2002;23:316–322. [PubMed]
2. Chen M-C, Harris JP, Keithley EM. Immunohistochemical analysis of proliferating cells in a sterile labyrinthitis animal model. Laryngoscope. 1998;108:651–656. [PubMed]
3. Harris JP. Immunology of the inner ear: Evidence of local antigen production. Ann. Otol. Rhinol. Laryngol. 1984;93:158–162.
4. Iwai H, Tomoda K, Sugiura K, Inaba M, Ikehara S, Yamashita T. T cells infiltrating from the systemic circulation proliferate in the endolymphatic sac. Ann. Otol. Rhinol. Laryngol. 1999;108:1146–1150. [PubMed]
5. Juhn SK. The nature of blood labyrinth barrier in experimental conditions. Ann. Otol. Rhinol. Laryngol. 1981;90:135–141. [PubMed]
6. Kanzaki J, Ouchi T. Steroid-responsive bilateral sensorineural hearing loss and immune complexes. Arch. Otolaryngol. 1981;230:5–9.
7. Kawauchi H, Ichimiya I, Kaneda N, Mogi G. Distribution of immunocompetent cells in the endolymphatic sac. Ann. Otol. Rhinol. Laryngol. 1992;101:39–47.
8. Ma C-L, Billings PB, Harris JP, Keithley EM. Characterization of an experimentally induced inner ear immune response: Laryngoscope. 2000;110:451–456. [PubMed]
9. McCabe BF. Autoimmune sensorineural hearing loss. Ann. Otol. Rhinol. Laryngol. 1992;88:585–589. [PubMed]
10. Rask-Andersen H, Stahle J. Lymphocyte–macrophage activity in the endolymphatic sac. An ultrastructural study of the rugose endolymphatic sac in the guinea pig. ORL J. Otorhinolaryngol. Relat. Spec. 1979;41:177–192.
11. Rask-Andersen H, Stahle J. Immunodefence of the inner ear? Lymphocyte–macrophage interaction in the endolymphatic sac. Acta Otolaryngol. Stockh. 1980;89:283–294. [PubMed]
12. Rask-Andersen H, Bagger–Sjoback D, Lundquist PG. The fenestrated blood vessels of the endolymphatic sac. A freeze-fracture and transmission electron microscopic study. Am. J. Otol. 1983;4:214–221. [PubMed]
13. Satoh H. Anti-glomerular basement membrane antibody-induced inflammation in rat cochlear plexus. Acta Otolaryngol. (Stockh.) 1997;117:80–86. [PubMed]
14. Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM. TNFα as an initiator and etanercept as a potential therapeutic inhibitor of inner ear inflammation. Laryngoscope. 2002;112:1627–1634. [PubMed]
15. Takahashi M, Harris JP. Anatomic distribution and localization of immunocompetent cells in normal mouse endolymphatic sac. Acta Otolaryngol. (Stockh.) 1988a;106:409–416. [PubMed]
16. Takahashi M, Harris JP. Analysis of immunocompetent cells following inner ear immunostimulation. Laryngoscope. 1988b;98:1133–1138. [PubMed]
17. Takahashi M, Tomiyama S. Cell proliferation in the endolymphatic sac in situ after inner ear immunostimulation. Acta Otolaryngol. (Stockh.) 1995;115:396–399. [PubMed]
18. Tomiyama S, Harris JP. The endolymphatic sac: its importance in inner ear immune responses. Laryngoscope. 1986;96:685–691. [PubMed]
19. Tomiyama S, Harris JP. The role of the endolymphatic sac in inner ear immunity. Acta Otolaryngol. (Stockh.) 1987;103:182–188. [PubMed]
20. Tomiyama S, Harris JP. Elevation of inner ear antibody levels following direct antigen challenge of the endolymphatic sac. Acta Otolaryngol. (Stockh.) 1989;107:202–209. [PubMed]
21. Wang X, Billings PB, Firestein GS, Harris JP, Keithley EM. Application of Enbrel in experimental immune-mediated sensorineural hearing loss. Assoc. Res. Otolaryngol. Abstr. 2002;25:92.
22. Yeo SW, Gotteschlich S, Harris JP, Keithley EM. Antigen diffusion from the perilymphatic space of the cochlea. Laryngoscope. 1995;105:623–628. [PubMed]
23. Yimtae K, Song H, Billings P, Harris JP, Keithley EM. Connection between the inner ear and the lymphatic system. Laryngoscope. 2001;111:1631–1635. [PubMed]

Articles from JARO: Journal of the Association for Research in Otolaryngology are provided here courtesy of Association for Research in Otolaryngology